CEO & Co-founder, DrugBank
Biography
Michael Wilson has over a decade of experience in bioinformatics and metabolomics research with a background in Biological and Computer Sciences. He has co-authored 19 scientific publications and one textbook, as well as participated in two international data exchange committees for bioinformatics data formats. As DrugBanks’s CEO and co-founder, Michael leads the strategic direction, operations, management, and business development teams. His guidance and vision keep the DrugBank team motivated and striving to deliver even more innovative products.
AI and Data Science Showcase:
DrugBank
DrugBank is the world’s first intelligent and comprehensive drug knowledge platform. With the help of artificial intelligence, our expert team authors, verifies, and structures all of the latest biomedical information so that it can be used to its fullest potential.
Session Abstract – PMWC 2023 Silicon Valley
Showcase Track S1 - January 25 9.00 A.M.-1.15 P.M.,Showcase Track S1 - January 26 11.30 A.M.-1.15 P.M.,Showcase Track S1 - January 27 11.00 A.M.-1.15 P.M.
The PMWC 2023 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
